Overview
Breast cancer forms in the breast when cells grow out of control forming a tumor. These tumors can be seen in an x-ray or often physically felt in the breast in the form of a lump or a mass. The tumor is considered cancerous or malignant if it begins to invade surrounding tissues or spread into other areas of the body (metastasize). Although breast cancer is predominantly found in women, men can also get breast cancer.
The American Cancer Society estimates approximately 250,000 cases of breast cancer in women in 2017. It is the most common cancer in women, with the exception of skin cancers1. Approximately 30% of new cancer cases in women will be attributed to breast cancers.2
1. https://www.cancer.org/cancer/breast-cancer/about/how-common-is-breast-cancer.html
2. (http://www.breastcancer.org/symptoms/understand_bc/statistics
Common symptoms can include:
A series of tests, procedures and scans are needed to diagnose cancer in the breast. These might include self-examination, imaging tests, or biopsies. Genomic tests are also performed to predict the risk of recurrence.
Breast cancer occurs in different areas of the breast such as ducts, lobules, or the tissue in between. Tumors can be non-invasive, invasive, recurrent, or metastatic. There are also molecular subtypes of breast cancer.
Albrighton Pharmacy, a specialty pharmacy for breast cancer, dispenses specialty and non-specialty breast cancer medications including (but not limited to):
Abraxane® (paclitaxel protein-bound particles for injectable suspension)
Kisqali® Femara® Co-pack (ribociclib, letrozole)
Albrighton Pharmacy also dispenses traditional chemotherapy medications as well as supportive care medications ordered by your prescriber that are not listed above.
Financial assistance coordination may be available to help with your medication costs, including manufacturer and community programs. Albrighton Pharmacy representatives are available to help find a program that may work for you.
There are many organizations that support research and advocacy for cancer. See below for a few of those organizations.
Are your customers raving about you on social media? Share their great stories to help turn potential customers into loyal ones.
Running a holiday sale or weekly special? Definitely promote it here to get customers excited about getting a sweet deal.
Overview
Brain cancer is broken out into primary or secondary tumors. Primary brain cancers are tumors that originated in the brain, whereas secondary brain cancer originated elsewhere in the body and metastasized in the brain. There are over 120 classifications of brain tumors such as gliomas, meningiomas, astrocytomas, glioblastomas, craniopharyngiomas, cerebral lymphomas, pituitary tumors and oligodendrogliomas.
There are estimated to be 23,800 new cases of brain and other nervous system cancers in the United States in 2017, which represents 1.4% of all cancers.1
Because the brain affects so many different organs and functions, symptoms of brain cancer can manifest differently, depending on factors such as the location, origin, and size of the tumor. Headaches, weakness, clumsiness, vision problems, seizures, vomiting, and mental status changes are examples of symptoms that may occur.
CT scans, MRI scans, and tissue biopsy are typically the tests used to diagnose brain cancer.
Medications
Afinitor® (everolimus) Novartis
Avastin® (bevacizumab) Genentech
Temodar® (temozolomide) Merck
Financial assistance coordination may be available to help with your medication costs, including manufacturer and community programs. Accredo representatives are available to help find a program that may work for you.
There are many organizations that support research and advocacy for cancer. See below for a few of those organizations
Lung cancer is broken out into two main subtypes, non-small cell lung cancer and small cell lung cancer. Typically, small cell lung cancer is less common in the United States. Non-small cell lung cancer is further classified by biomarkers that are present in some subtypes. The first classification of non-small cell lung cancer is by histology, or shape/origin of the cells. Non-small cell lung cancer is broken out into adenocarcinoma, large cell, and squamous cell lung cancer. Within the adenocarcinoma subpopulation, there are markers that can be tested for by your physician to help determine which treatments are most appropriate for your disease. These include, but aren’t limited to, EGFR (epithelial growth factor receptor), ALK (anaplastic lymphoma kinase), and ROS1 (receptor tyrosine kinase) mutations. More therapies are being developed to target unique types of lung cancer each day.
There are estimated to be 222,500 lung cancer cases in the United States in 2017. The American Cancer Society cites that 85% are non-small cell lung cancer.1
. https://seer.cancer.gov/statfacts/html/lungb.html
Signs and symptoms of lung cancer may include: shortness of breath, chest pain, wheezing, presence of a new persistent cough, coughing up blood, weight loss, loss of appetite, bone pain.
Diagnosis of lung cancer may include imaging tests such as an x-ray or CT scan, but more definitively diagnosed using histological examination of the tissue from a biopsy.
Albrighton Pharmacy, a specialty pharmacy for lung cancer, dispenses specialty and non-specialty lung cancer medications including (but not limited to):
Abraxane® (paclitaxel protein-bound particles for injectable suspension)
Hycamtin® (topotecan injection)
Albrighton Pharmacy also dispenses traditional chemotherapy medications as well as supportive care medications ordered by your prescriber that are not listed above.
Financial assistance coordination may be available to help with your medication costs, including manufacturer and community programs. Albrighton Pharmacy representatives are available to help find a program that may work for you.
There are many organizations that support research and advocacy for cancer. See below for a few of those organizations
Copyright © 2017 ALBRIGHTON GROUP - All Rights Reserved.